NAPRELAN

Compare NAPRELAN  to:
Compare
Compare

Generic Name for NAPRELAN

Naproxen (as sodium) 375mg, 500mg, 750mg; controlled rel tabs.

Legal Classification:

Rx

Pharmacological Class for NAPRELAN

NSAID (arylacetic acid deriv.).

Manufacturer of NAPRELAN

Victory Pharma

Indications for NAPRELAN

Mild to moderate pain.

Adult dose for NAPRELAN

1g once daily, or 1.5g once daily for a limited period; max 1g/day thereafter.

Children's dosing for NAPRELAN

Not recommended.

Contraindications for NAPRELAN

Aspirin allergy. 3rd trimester pregnancy. Coronary artery bypass graft surgery.

Precautions for NAPRELAN

Advanced renal disease: not recommended. Active peptic ulcer. History of GI disease. Impaired renal or hepatic function. Heart failure. Edema. Hypertension. Pre-existing asthma. Bleeding disorders. Monitor blood, ocular, and liver function in chronic use. Discontinue if liver dysfunction occurs. Elderly. Debilitated. Pregnancy (Cat.C). Nursing mothers: not recommended.

Interactions for NAPRELAN

Avoid aspirin. Serum levels increased by probenecid. May potentiate protein-bound drugs (eg, phenytoin, sulfonylureas, sulfonamides). Monitor oral anticoagulants. May antagonize diuretics, antihypertensives. Increased renal toxicity with ACE inhibitors. Methotrexate excretion reduced. Increases lithium levels. Increased risk of GI bleed with alcohol.

Adverse Reactions for NAPRELAN

GI upset, bleeding, or ulceration; headache, flu syndrome, constipation, abdominal pain, dizziness, paresthesias, insomnia, rash (discontinue if occurs), edema, hyperglycemia, arthralgia, myalgia, renal dysfunction, blood dyscrasias, others. See literature re: risk of cardiovascular events.

How is NAPRELAN supplied?

Tabs 375mg—100
500mg—75
750mg—30
Dose card (10-day therapy)—20 (750mg x 6 tabs + 500mg x 14 tabs)

Related Disease:

Pain, general~nonnarcotics

Related Resources

Exel/Exelint infusion set needles recalled

January 26, 2010

FDA notified healthcare professionals of a Class I recall of Exel/Exelint Huber needles, Exel/Exelint Huber Infusion Sets, and Exel/Exelint "Securetouch+" Safety Huber Infusion Sets due to 'coring,' the cutting or dislodging of silicone cores or slivers from the ports into which they are inserted).

McNeil Consumer Healthcare recalls certain over-the-counter (OTC) products

January 15, 2010

McNeil Consumer Healthcare and the FDA have announced a voluntary recall of certain lots of over-the-counter products, including Tylenol (acetaminophen), Motrin IB (ibuprofen), St. Joseph Aspirin (aspirin), Simply Sleep (diphenhydramine), and Rolaids (calcium carbonate and magnesium hydroxide).

Naprelan Dose Card blister packs launched

November 23, 2009

Victory Pharma announces the availability of Naprelan (naproxen) Dose Card, a single blister pack which provides a ten day, tapered dose regimen of naproxen.

Phase 2 study of Civamide Patch for post-herpetic neuralgia (PHN)

November 16, 2009

Winston Laboratories announced positive top-line results from Study WL1001-04-03, a Phase 2 clinical trial evaluating the safety and efficacy of the company's patch formulation of Civamide in the treatment of post-herpetic neuralgia (PHN).

Lusedra available for monitored anesthesia care sedation

November 16, 2009

Eisai has made available Lusedra (fospropofol disodium injection), an intravenous water-soluble prodrug of the sedative-hypnotic agent propofol, for monitored anesthesia care (MAC) sedation in adult patients undergoing diagnostic or therapeutic procedures.